My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 314

    1.

    The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial.

    Pimentel M, Park S, Mirocha J, Kane SV, Kong Y.

    Ann Intern Med. 2006 Oct 17;145(8):557-63.PMID: 17043337 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. Can antibiotics improve the symptoms of the irritable bowel syndrome?

    [No authors listed]

    Ann Intern Med. 2006 Oct 17;145(8):I24. No abstract available. PMID: 17043334 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Role of gut microflora and probiotic effects in the irritable bowel syndrome.

    Fanigliulo L, Comparato G, Aragona G, Cavallaro L, Iori V, Maino M, Cavestro GM, Soliani P, Sianesi M, Franzè A, Di Mario F.

    Acta Biomed. 2006 Aug;77(2):85-9.PMID: 17172187 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence.

    Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I.

    Am J Gastroenterol. 2006 Feb;101(2):326-33.PMID: 16454838 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.

    Evans BW, Clark WK, Moore DJ, Whorwell PJ.

    Cochrane Database Syst Rev. 2007 Oct 17;(4):CD003960. Review.PMID: 17943807 [PubMed - indexed for MEDLINE]Related articles

    6.

    Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.

    Aliment Pharmacol Ther. 2005 Feb 15;21(4):435-44.PMID: 15709995 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea.

    DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, DuPont MW, Martinez-Sandoval F.

    Ann Intern Med. 2005 May 17;142(10):805-12. Erratum in: Ann Intern Med. 2005 Aug 2;143(3):239. PMID: 15897530 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome]

    Tegaserod Clinical Research Group.

    Zhonghua Nei Ke Za Zhi. 2003 Feb;42(2):88-90. Chinese. PMID: 12783702 [PubMed - indexed for MEDLINE]Related articles

    9.

    A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome.

    Nyhlin H, Bang C, Elsborg L, Silvennoinen J, Holme I, Rüegg P, Jones J, Wagner A.

    Scand J Gastroenterol. 2004 Feb;39(2):119-26.PMID: 15000272 [PubMed - indexed for MEDLINE]Related articles

    10.

    A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.

    Taylor DN, Bourgeois AL, Ericsson CD, Steffen R, Jiang ZD, Halpern J, Haake R, Dupont HL.

    Am J Trop Med Hyg. 2006 Jun;74(6):1060-6.PMID: 16760520 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.

    Krause R, Ameen V, Gordon SH, West M, Heath AT, Perschy T, Carter EG.

    Am J Gastroenterol. 2007 Aug;102(8):1709-19. Epub 2007 May 17.PMID: 17509028 [PubMed - indexed for MEDLINE]Related articles

    12.

    Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.

    Isaacs KL, Sandler RS, Abreu M, Picco MF, Hanauer SB, Bickston SJ, Present D, Farraye FA, Wolf D, Sandborn WJ; Crohn's and Colitis Foundation of America Clinical Alliance.

    Inflamm Bowel Dis. 2007 Oct;13(10):1250-5.PMID: 17567869 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Herbal medicine with curcuma and fumitory in the treatment of irritable bowel syndrome: a randomized, placebo-controlled, double-blind clinical trial.

    Brinkhaus B, Hentschel C, Von Keudell C, Schindler G, Lindner M, Stützer H, Kohnen R, Willich SN, Lehmacher W, Hahn EG.

    Scand J Gastroenterol. 2005 Aug;40(8):936-43.PMID: 16173134 [PubMed - indexed for MEDLINE]Related articles

    14.

    Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.

    Drossman DA, Danilewitz M, Naesdal J, Hwang C, Adler J, Silberg DG.

    Am J Gastroenterol. 2008 Oct;103(10):2562-9. Epub 2008 Sep 4.PMID: 18775020 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.

    Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S.

    Health Technol Assess. 2006 Jun;10(19):iii-iv, ix-x, 1-67.PMID: 16729918 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials.

    Lembo AJ, Olden KW, Ameen VZ, Gordon SL, Heath AT, Carter EG.

    Clin Gastroenterol Hepatol. 2004 Aug;2(8):675-82.PMID: 15290660 [PubMed - indexed for MEDLINE]Related articles

    17.

    Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS.

    Yang J, Lee HR, Low K, Chatterjee S, Pimentel M.

    Dig Dis Sci. 2008 Jan;53(1):169-74. Epub 2007 May 23.PMID: 17520365 [PubMed - indexed for MEDLINE]Related articles

    18.

    A preliminary study of melatonin in irritable bowel syndrome.

    Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P.

    J Clin Gastroenterol. 2007 Jan;41(1):29-32.PMID: 17198061 [PubMed - indexed for MEDLINE]Related articles

    19.

    High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.

    Scarpellini E, Gabrielli M, Lauritano CE, Lupascu A, Merra G, Cammarota G, Cazzato IA, Gasbarrini G, Gasbarrini A.

    Aliment Pharmacol Ther. 2007 Apr 1;25(7):781-6.PMID: 17373916 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.

    Chang FY, Lu CL, Chen CY, Luo JC.

    J Gastroenterol Hepatol. 2007 Dec;22(12):2266-72. Epub 2007 Jun 7.PMID: 17559369 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity